A. Piluso

831 total citations
23 papers, 640 citations indexed

About

A. Piluso is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, A. Piluso has authored 23 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 9 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in A. Piluso's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (6 papers). A. Piluso is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (6 papers). A. Piluso collaborates with scholars based in Italy. A. Piluso's co-authors include Anna Linda Zignego, Laura Gragnani, Monica Monti, Elisa Fognani, Jessica Ranieri, Teresa Urraro, Giacomo Laffi, Carlo Giannini, Alessio Fabbrizzi and Patrizio Caini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

A. Piluso

23 papers receiving 633 citations

Peers

A. Piluso

HEPAT

EPIDE

RHEUM

GENET

SURGE

I Damilano Italy

Cathryn A. Scott Italy

Mitsuaki Kaizuka Japan

L. Iannaccone Italy

Hiroyuki Hagiyama Japan

Marian H. Miller Australia

Akitomo Okada Japan

Takao Nagashima Japan

Ken Watanabe Japan

Masayuki Yamakura Japan

I Damilano Italy

A. Piluso

273 ×0.6

HEPAT

126 ×0.5

EPIDE

101 ×0.5

RHEUM

97 ×0.9

GENET

161 ×1.8

SURGE

Citations per year, relative to A. Piluso A. Piluso (= 1×) peers I Damilano

Countries citing papers authored by A. Piluso

Since Specialization

Citations

This map shows the geographic impact of A. Piluso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Piluso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Piluso more than expected).

Fields of papers citing papers by A. Piluso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Piluso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Piluso. The network helps show where A. Piluso may publish in the future.

Co-authorship network of co-authors of A. Piluso

This figure shows the co-authorship network connecting the top 25 collaborators of A. Piluso. A scholar is included among the top collaborators of A. Piluso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Piluso. A. Piluso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gragnani, Laura, A. Piluso, Teresa Urraro, et al.. (2016). Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study. Current Drug Targets. 18(7). 772–785. 42 indexed citations

Visentini, Marcella, Carmine Tinelli, Stefania Colantuono, et al.. (2015). Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review. Autoimmunity Reviews. 14(10). 889–896. 46 indexed citations

Basile, Umberto, Laura Gragnani, A. Piluso, et al.. (2015). Assessment of free light chains in HCV‐positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment. Liver International. 35(9). 2100–2107. 17 indexed citations

Piluso, A., Laura Gragnani, Elisa Fognani, et al.. (2015). Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies. Hepatology International. 9(4). 586–593. 7 indexed citations

Basile, Umberto, Laura Gragnani, A. Piluso, et al.. (2015). Assessment of free light chains in HCV positive patients with mixed cryoglobulinemia vasculitis undergoing rituximab treatment. Digestive and Liver Disease. 47. e27–e27. 1 indexed citations

Piluso, A., et al.. (2015). O060 : MIR-17/92 expression pattern: A molecular signature of HCV-related mixed cryoglobulinemia. Journal of Hepatology. 62. S221–S221. 1 indexed citations

Urraro, Teresa, Laura Gragnani, A. Piluso, et al.. (2015). Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy. SHILAP Revista de lepidopterología. 2015. 1–5. 28 indexed citations

Gragnani, Laura, Alessio Fabbrizzi, Teresa Urraro, et al.. (2014). Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. Digestive and Liver Disease. 46(9). 833–837. 55 indexed citations

Gragnani, Laura, Elisa Fognani, A. Piluso, et al.. (2014). Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study. Hepatology. 61(4). 1145–1153. 98 indexed citations

10.

Zignego, Anna Linda, Laura Gragnani, A. Piluso, et al.. (2014). Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Review of Clinical Immunology. 11(1). 15–31. 66 indexed citations

11.

Fognani, Elisa, Carlo Giannini, A. Piluso, et al.. (2013). Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia. PLoS ONE. 8(5). e62965–e62965. 39 indexed citations

12.

Fognani, Elisa, A. Piluso, Laura Gragnani, et al.. (2013). 454 microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA. Journal of Hepatology. 58. S185–S186. 5 indexed citations

13.

Zignego, Anna Linda, Carlo Giannini, Laura Gragnani, A. Piluso, & Elisa Fognani. (2012). Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact. Journal of Translational Medicine. 10(1). 158–158. 17 indexed citations

14.

Visentini, Marcella, Serena Ludovisi, A. Petrarca, et al.. (2011). A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmunity Reviews. 10(11). 714–719. 58 indexed citations

15.

Gragnani, Laura, A. Piluso, Carlo Giannini, et al.. (2011). Genetic determinants in hepatitis C virus–associated mixed cryoglobulinemia: Role of polymorphic variants of BAFF promoter and Fcγ receptors. Arthritis & Rheumatism. 63(5). 1446–1451. 53 indexed citations

16.

Zignego, Anna Linda, A. Piluso, & Carlo Giannini. (2008). HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation. Autoimmunity Reviews. 8(2). 107–111. 29 indexed citations

17.

Anselmi, B., Roberto Tarquini, Alessandro Panconesi, et al.. (1997). Serum beta-endorphin increase after intravenous histamine treatment of chronic daily headache.. PubMed. 88(7-8). 321–4. 15 indexed citations

18.

Perfetto, Federico, et al.. (1997). Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus.. PubMed. 88(7-8). 317–20. 8 indexed citations

19.

Tarquini, Roberto, et al.. (1996). Serum melatonin in multiple myeloma: natural brake or epiphenomenon?. PubMed. 15(6B). 2633–7. 6 indexed citations

20.

Perfetto, Federico, et al.. (1995). Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients. Acta Diabetologica. 32(4). 263–267. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact